Literature DB >> 19156485

A clinically isolated syndrome: a challenging entity: multiple sclerosis or collagen tissue disorders: clues for differentiation.

Asli Kurne1, Ilksen Colpak Isikay, Kader Karlioguz, Umut Kalyoncu, Omer Faruk Aydin, Meral Calguneri, Rana Karabudak.   

Abstract

Acute isolated neurological syndromes, such as optic neuropathy or transverse myelopathy, may cause diagnostic problems since they can be the first presentations of a number of diseases such as multiple sclerosis (MS) and collageneous tissue disorders. In the present study, particular systemic lupus erythematosus (SLE) and primary Sjogren syndrome (pSS) patients, who were followed up with the initial diagnosis of possible MS with no evidence of collagen tissue disorders for several years, are described. Five patients with the final diagnosis of SLE and five pSS patients are evaluated with their neurologic, systemic and radiologic findings.Over several years, all developed some systemic symptoms like arthritis, arthralgia, headache, dry mouth and eyes unexpected in MS. During the regular and close follow-up laboratory evaluations of vasculitic markers revealed positivity, leading to the final definite diagnosis of SLE or pSS. Patients with atypical neurological presentation of MS, a relapsing remitting clinical profile, or lack of response to the regular MS treatment should be evaluated for the presence of a connective tissue disease. Various laboratory tests, such as cerebrospinal fluid findings, autoantibodies profile, markers, cranial and spinal magnetic resonance imaging, can be helpful for the differential diagnosis. Lack of response to the regular multiple sclerosis treatment, even increasing rate of relapses can force the clinician for the differential diagnosis. In particular cases an accurate diagnosis can only be made after close follow-up.

Entities:  

Mesh:

Year:  2009        PMID: 19156485     DOI: 10.1007/s00415-008-0882-y

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  51 in total

1.  Neurological picture. Acute longitudinal myelitis as the initial manifestation of Sjögren's syndrome.

Authors:  T Yamamoto; S Ito; T Hattori
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06       Impact factor: 10.154

2.  Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications.

Authors:  R Molina; T T Provost; E L Alexander
Journal:  Arthritis Rheum       Date:  1985-12

Review 3.  The differential diagnosis of multiple sclerosis.

Authors:  Loren A Rolak; John O Fleming
Journal:  Neurologist       Date:  2007-03       Impact factor: 1.398

Review 4.  Lupus and the central nervous system.

Authors:  S G West
Journal:  Curr Opin Rheumatol       Date:  1996-09       Impact factor: 5.006

Review 5.  Primary Sjögren syndrome in childhood: report of a case and review of the literature.

Authors:  Nikolaos G Nikitakis; Helen Rivera; Carmela Lariccia; John C Papadimitriou; John J Sauk
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2003-07

6.  A subgroup of multiple sclerosis patients with anticardiolipin antibodies and unusual clinical manifestations: do they represent a new nosological entity?

Authors:  D Karussis; R R Leker; A Ashkenazi; O Abramsky
Journal:  Ann Neurol       Date:  1998-10       Impact factor: 10.422

7.  Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies.

Authors:  David P D'Cruz; Susana Mellor-Pita; Beatriz Joven; Giovanni Sanna; Judith Allanson; James Taylor; Munther A Khamashta; Graham R V Hughes
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

Review 8.  MRI and the brain in systemic lupus erythematosus.

Authors:  J W Graham; W Jan
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 9.  APS and the brain.

Authors:  J Sastre-Garriga; X Montalban
Journal:  Lupus       Date:  2003       Impact factor: 2.911

Review 10.  Acute transverse myelopathy and cutaneous vasculopathy in primary Sjögren's syndrome.

Authors:  R K Lyu; S T Chen; L M Tang; T C Chen
Journal:  Eur Neurol       Date:  1995       Impact factor: 1.710

View more
  6 in total

Review 1.  The radiologically isolated syndrome: take action when the unexpected is uncovered?

Authors:  Johann Sellner; Lucas Schirmer; Bernhard Hemmer; Mark Mühlau
Journal:  J Neurol       Date:  2010-05-26       Impact factor: 4.849

Review 2.  [Neuroimmunology and rheumatology: overlap and differential diagnoses].

Authors:  C Trebst; T Kümpfel
Journal:  Nervenarzt       Date:  2018-10       Impact factor: 1.214

3.  cDNA microarray analysis identifies NR4A2 as a novel molecule involved in the pathogenesis of Sjögren's syndrome.

Authors:  H Takahashi; H Tsuboi; H Asashima; T Hirota; Y Kondo; M Moriyama; I Matsumoto; S Nakamura; T Sumida
Journal:  Clin Exp Immunol       Date:  2017-07-21       Impact factor: 4.330

4.  Frequency of autoantibodies and connective tissue diseases in Chinese patients with optic neuritis.

Authors:  Hongyang Li; Yan Zhang; Zuohuizi Yi; Dehui Huang; Shihui Wei
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

5.  CNS inflammation other than multiple sclerosis: how likely is diagnosis?

Authors:  Duncan Street; Christopher A Halfpenny; Ian Galea
Journal:  Neurology       Date:  2014-02-28       Impact factor: 9.910

6.  A challenging entity: multiple sclerosis or collagen tissue disorders: A case series of 6 patients.

Authors:  Raida Ben Salah; Yosra Cherif; Faten Frikha; Dammak Chifaa; Mouna Snoussi; Moez Jallouli; Sameh Marzouk; Mhiri Chokri; Zouhir Bahloul
Journal:  Caspian J Intern Med       Date:  2017
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.